NovoPen® 3

DEVICE2 trials

Sponsors

Novo Nordisk A/S

Conditions

Delivery SystemsDiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Phase 3

Comparison of Two Pen Systems in Patients With Diabetes Treated With Insulin

CompletedNCT00569998

Novo Nordisk A/SDelivery Systems, Diabetes, Diabetes Mellitus, Type 1 +1

Start: 2003-08-31End: 2004-02-29Updated: 2017-01-19

Unknown Phase

Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice

CompletedNCT01454024

Novo Nordisk A/SDelivery Systems, Diabetes, Diabetes Mellitus, Type 1 +1

Start: 2011-11-30End: 2012-10-31Updated: 2015-06-12